|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.20 DKK | -4.72% |
|
-11.79% | +81.98% |
| 08/06 | Curasight Announces Preliminary Readout from Phase 1 Clinical Trial with uTREAT In Aggressive Brain Cancer | CI |
| 08/06 | Curasight reports promising Phase 1 data in aggressive brain cancer | FW |
Executive Committee: Curasight A/S
| Manager | Positions heldSince | ||||||
|---|---|---|---|---|---|---|---|
![Ulrich Krasilnikoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Ulrich Krasilnikoff 59 year |
| ||||||
Hanne Jensen |
| ||||||
Andreas Kjær 63 year |
| ||||||
Nic Gillings 58 year |
|
Composition of the Board of Directors: Curasight A/S
| Director | CommitteesSince | ||||
|---|---|---|---|---|---|
Kirsten Drejer 69 year |
| ||||
Charlotte Vedel 58 year |
| ||||
Andreas Kjær 63 year |
| ||||
Lars Trolle 59 year |
| ||||
Ulrich Krasilnikoff 59 year |
|
Latest Appointments: Curasight A/S
Former Officers and Directors: Curasight A/S
| Insider | Positions held SinceUntil | ||||||
|---|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 8 |
|---|---|
| Female | 1 |
Of which Executive Committee
| Male | 3 |
|---|---|
| Female | 1 |
Of which Directors
| Male | 5 |
|---|---|
| Female | 0 |
Departures of Key Persons
Chairman
01/01/2020 -
Chief Executive Officer
01/01/2013 -
Select your edition
All financial news and data tailored to specific country editions
